I. Slater

发表

Plasma concentrations and electrocardiographic alterations after repetitive administration of propoxyphene to dogs.

J. Page, H. Sullivan, S. L. Due, 1979, Toxicology and applied pharmacology.

Somatostatin inhibits adrenergic and cholinergic neurotransmission in smooth muscle.

M. Cohen, K. Wiley, I. Slater, 1978, Life sciences.

2 – DIABETES INSIPIDUS AND ITS DIFFERENTIAL DIAGNOSIS

R. Bodo, I. Slater, I. H. Slater, 2013 .

Inhibition of REM sleep by fluoxetine, a specific inhibitor of serotonin uptake

R. Moore, I. Slater, G. T. Jones, 1978, Neuropharmacology.

Blocking of inhibitory adrenergic receptors by a dichloro analog of isoproterenol.

C E POWELL, I H SLATER, I. Slater, 1958, The Journal of pharmacology and experimental therapeutics.

The action of some derivatives of beta-erythroidine on peripheral neuro-effector systems.

D. Megirian, I. Slater, D. E. Leary, 1955, The Journal of pharmacology and experimental therapeutics.

Daily rhythm of liver tyrosine transaminase and of plasma tyrosine and glucose after removal of the pancreas of rats.

R. Fuller, H. Snoddy, I. Slater, 1969, Life sciences.

N-substituted cyclopropylamines as monoamine oxidase inhibitors. Structure-activity relationships. Dopa potentiation in mice and in vitro inhibition of kynuramine oxidation.

R. Fuller, I. Slater, J. Mills, 1968, Journal of medicinal chemistry.

Amitriptyline and nortriptyline as antagonists of central and peripheral cholinergic activation

R. C. Rathbun, I. Slater, 1963, Psychopharmacologia.

The pressor effect of histamine after autonomic ganglionic blockade.

P. Dresel, I. Slater, I. H. Slater, 1952, The Journal of pharmacology and experimental therapeutics.